Analysis of all results reported on 20th Aug 2020

Analysis of all results reported on 20th Aug 2020 PS: Data for education purpose only, use ur own discretion. Views on results may wary as per individual analysis Good results Lincoln Pharma.Sales up 7%, ebidta up 16%, pat up 20.4%9x ttm p/e22% roce Expleo SolutionsSales up 24.5%, ebidta up 87%, pat up 115%10x ttm p/e36% roceIndia based software service provider primarily delivering software validation and verifi cation services to the banking, fi nancial services and insurance industry worldwide WEAKSheela FoamSales…

Continue Reading

Analysis of all results reported on 19th Aug 2020

Analysis of all results reported on 19th Aug 2020 PS: Data for education purpose only, use ur own discretion. Views on results may wary as per individual analysis For all fans of Ruchi Soya Inds.Sales at 3043 cr vs 3113 crEbidta at 124 cr vs 36 crPat at 12 cr vs loss of 4 cr GoodAshapura MinechemSales up 150%, ebidta up 529%, pat up 5173%Sales at 286 cr vs 115 crEbidta at 27 cr vs 4 crMargins at 9.6% vs…

Continue Reading

Analysis of all results reported on 18th Aug 2020

Analysis of all results reported on 18th Aug 2020 PS: Data for education purpose only, use ur own discretion. Views on results may wary as per individual analysis GoodKNR ConstructionSales down 1.5%, ebidta up 12.3%, pat up 8.8%Margins at 25% vs 21.8%12x ttm p/e UflexSales up 0.7%, ebidta up 52%, pat up 116%Margins at 20.9% vs 13.8%Stock up from 118 to 3386.6x ttm p/ePackaging cos have done v well this quarter FACTSales up 57% at 552 cr, ebidta at 32…

Continue Reading

Analysis of all results reported on 17th Aug 2020

Analysis of all results reported on 17th Aug 2020 PS: Data for education purpose only, use ur own discretion. Views on results may wary as per individual analysis GOODSuven PharmaSales up 20%, ebidta up 9%, pat flatStock has run up 300% from 52-week low28x ttm p/e56% roce Lux IndSales down 6%, ebidta up 30%, pat up 66%Margins at 18.5% vs 13.3%Cost control benefit + integration with another co27x ttm p/e WEAKHLE GlascoatSales down 8%, ebidta down 4%, pat down 17%47x…

Continue Reading

Analysis of all results reported on 14th Aug 2020

Analysis of all results reported on 14th Aug 2020 PS: Data for education purpose only, use ur own discretion. Views on results may wary as per individual analysis PATAKANA V STRONGPolyplex CorpSales up 4% at 1160 cr (could have been better)Ebidta surged to 312 cr vs 223 crMargins at 26.9% vs 20%Pat at 179 cr vs 81 cr Trigyn Techno.Sales at 249 cr vs 236 cr qoqEbidta at 25 cr vs 11 cr qoqMargins at 10.2% vs 4.9% qoqPat at…

Continue Reading

Analysis of all results reported on 10th Aug 2020

Analysis of all results reported on 10th Aug 2020 PS: Data for education purpose only, use ur own discretion. Views on results may wary as per individual analysis PATAKANA GOODIPCA LabsSales up 42%, ebidta double, profit up 245%28x ttm Caplin PointGood but not greatSales up 24.7%, ebidta up 6.3%, pat up 8.6%Track receivables closely19.7x ttm p/ehttps://www.bseindia.com/xml-data/corpfiling/AttachLive/43bf7456-72c0-461e-89d8-a4babab6b550.pdf Camlin FineSales up 17%, ebidta up 43%, pat at 15 cr vs 16 cr yoy, vs 3 cr qoqMargins at 16.7% vs 13.7% Quick…

Continue Reading

Analysis of all results reported on 7th and 8th Aug 2020

Analysis of all results reported on 7th and 8th Aug PS: Data for education purpose only, use ur own discretion. Views on results may wary as per individual analysis PATAKADivisSales up 49%, EBIDTA up 81%, PAT up 80%Focus on growth in sales on HUGE base40% margins vs 33.3%All round upgrade from brokerage reports Shilpa MedicareSales up 38%, ebidta up 128%pat up 448% at 86 cr vs 16 cr30% margins vs 18%30x ttm p/e SCISales at 1143 cr vs 933 crEbidta…

Continue Reading

Analysis of results reported on 5th Aug 2020

Analysis of results reported on 5th Aug 2020 PS: Data for education purpose only, use ur own discretion. Views on results may wary as per individual analysis GOODEID Parry: standalone okish – cons super due to coroCons: Sales up 32%, EBIDTA at 431 cr vs 161 cr, margins at 10.4% vs 5.1%, profit at 29 cr vs loss of 28 cr - Cons numbers include Coromandal Int Standalone sales at 508 cr vs 407 cr; profit at 225 cr vs…

Continue Reading

Analysis of results declared on 4th Aug 2020

Analysis of results declared on 4th Aug 2020 PS: Data for education purpose only, use ur own discretion. Views on results may wary as per individual analysis. Godrej Cons: SOLID resultsCS on Godrej Consumer: Increases target price to Rs 830 (from Rs800)Jefferies on Godrej Consumer: Upgrade to buy & increases target price to Rs 820 from Rs 550 Tata Cons: SUPER GOOD (65x TTM) PATAKASPARC – WoW numbersVVVV lumpy numbers - profit after 8 quarters of lossesHighest profit in last…

Continue Reading

Analysis of results declared 3rd Aug 2020

Analysis of results declared on 3rd Aug 2020PS: Data for education purpose only, use ur own discretion. Views on results may wary as per individual analysis GOODSolara Active Pharma ScienceNet profit up 59.4%Revenue up 5.5%Margins at 28.5% vs 23.5%Ttm p/e 19xOperating leverage delivering highest ever EBITDA in a quarterhttps://www.bseindia.com/xml-data/corpfiling/AttachLive/015008a6-4371-4af2-9ea1-b1828bf2532f.pdf OkishBSE LtdSales at 133 cr vs 161 cr due to Lower listing fess and transaction chargesEbidta at 40 cr vs 51 cr yoy, vs 8 cr qoqPat at 32 cr vs…

Continue Reading
Close Menu